W. Mcgirr David - Jun 21, 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Director
Signature: /s/ Hunter Smith, attorney-in-fact for David W.J. McGirr
Stock symbol: RYTM
Transactions as of: Jun 21, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/23/2023, 04:31 PM
Previous filing: Jun 14, 2023
Next filing: May 15, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYTM	Stock Option (right to buy)	Award	$0	+14K		$0.00	14K	Jun 21, 2023	Common Stock	14K	$18.47	Direct	F1
transaction	RYTM	Restricted Stock Units	Award	$0	+3K		$0.00	3K	Jun 21, 2023	Common Stock	3K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date.
F2	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F3	The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.